Compare ASUR & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASUR | ANIK |
|---|---|---|
| Founded | 1985 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.4M | 200.9M |
| IPO Year | 1996 | 1996 |
| Metric | ASUR | ANIK |
|---|---|---|
| Price | $8.17 | $15.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $14.33 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 123.5K | 61.4K |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 80.16 |
| EPS | ★ 0.02 | N/A |
| Revenue | $88,952,000.00 | ★ $112,819,000.00 |
| Revenue This Year | $16.33 | $5.98 |
| Revenue Next Year | $9.20 | $7.42 |
| P/E Ratio | $409.50 | ★ N/A |
| Revenue Growth | ★ 63.39 | N/A |
| 52 Week Low | $6.80 | $7.90 |
| 52 Week High | $11.47 | $16.24 |
| Indicator | ASUR | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 46.60 | 59.20 |
| Support Level | $7.87 | $13.88 |
| Resistance Level | $8.70 | $15.93 |
| Average True Range (ATR) | 0.43 | 0.46 |
| MACD | -0.00 | 0.09 |
| Stochastic Oscillator | 46.30 | 91.38 |
Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.